Target intelligence / Profile preview

RNA, Ro-associated Y4 pseudogene 29 (RNY4P29)

Target
RNY4P29
Molecular classification
Other (pseudogene, non-coding RNA related)
01

Overview

RNY4P29, or RNA, Ro-associated Y4 pseudogene 29, is a member of the RNY4 pseudogene family—a group of genomic sequences highly homologous to the RNY4 small non-coding RNA but lacking evidence of independent transcription or distinct biological activity[2][3]. Functional RNY4 is a Y RNA component of ribonucleoprotein complexes (notably with Ro60 and La autoantigens), involved in RNA stability, DNA replication, and possibly regulation of immune responses and cancer progression[1][2]. Several RNY4 pseudogenes (such as RNY4P7, RNY4P10, and RNY4P20) have been detected as DNA sequences or RNA fragments in some sequencing studies, but RNY4P29 specifically does not have demonstrated function, and RNY4-derived fragments studied as potential biomarkers are from the parent RNY4 locus, not its pseudogenes[1][2]. There is no evidence that RNY4P29 is a receptor, enzyme, or therapeutic target, nor that it independently impacts disease[1][2][3].

Other names
RNY4P29RNA, Ro-associated Y4 pseudogene 29

Beyond the preview

Go deeper on RNA, Ro-associated Y4 pseudogene 29 (RNY4P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 29 (RNY4P29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call